Cardiovascular adverse events associated with cyclophosphamide, pegylated liposomal doxorubicin, vincristine, and prednisone with or without rituximab ((R)-CDOP) in non-Hodgkin's lymphoma: A systematic review and meta-analysis

• المؤلفون الرئيسيون: Bin Lu (مؤلف), Longfei Shen (مؤلف), Ying Ma (مؤلف), Jia Qi (مؤلف), Yulin Li (مؤلف), Zhihao Wang (مؤلف), Lu Han (مؤلف), Ming Zhong (مؤلف)
• التنسيق: كتاب
• منشور في: Frontiers Media S.A., 2022-12-01T00:00:00Z.
• الموضوعات: article
• الوصول للمادة أونلاين: Connect to this object online.

Background: The (R)-CDOP combination regimen, based on pegylated liposomal doxorubicin, is increasingly used for elderly patients with non-Hodgkin's lymphoma. However, the cardiotoxicity and efficacy of the (R)-CDOP regimen compared with conventional anthracyclines have not been demonstrated in...